Breast and cervical cancer patients' experience in Addis Ababa city, Ethiopia: a follow-up study protocol.

Alem Gebremariam, Adamu Addissie, Alemayehu Worku, Selamawit Hirpa, Mathewos Assefa, Lydia E Pace, Eva Johanna Kantelhardt, Ahmedin Jemal
Author Information
  1. Alem Gebremariam: Public Health, College of Medicine and Health Sciences, Adigrat University, Adigrat, Tigray, Ethiopia. ORCID
  2. Adamu Addissie: Preventive Medicine, Addis Ababa University School of Public Health, Addis Ababa, Ethiopia.
  3. Alemayehu Worku: Preventive Medicine, Addis Ababa University School of Public Health, Addis Ababa, Ethiopia.
  4. Selamawit Hirpa: Preventive Medicine, Addis Ababa University School of Public Health, Addis Ababa, Ethiopia.
  5. Mathewos Assefa: Oncology, Addis Ababa University School of Medicine, Addis Ababa, Ethiopia.
  6. Lydia E Pace: Brigham and Women's Hospital, Boston, Massachusetts, USA.
  7. Eva Johanna Kantelhardt: Institute of Medical Epidemiology, Biostatistics and Informatics, Martin-Luther-University, Halle, Germany. ORCID
  8. Ahmedin Jemal: Surveillance and Health Services Research, American Cancer Society, Atlanta, Georgia, USA.

Abstract

INTRODUCTION: Cancer is an emerging public health problem in Ethiopia, with breast and cervical cancers accounting for over half of all newly diagnosed cancers in women. The majority of women with breast and cervical cancer are diagnosed at late stage of the disease and most patients do not receive care consistent with global standards. However, little is known about the health-seeking behaviours, barriers to early detection and treatment, patient-reported outcomes, financial burden and survival of women with breast and cervical cancer in the country. Therefore, this study aims to document the experience of women with breast and cervical cancer from recognition of symptoms to diagnosis, treatment and survivorship/mortality in Addis Ababa city, Ethiopia.
METHODS AND ANALYSIS: A prospective follow-up study using mixed methods (both quantitative and qualitative) will be employed. All women newly diagnosed with breast and cervical cancer from 1 January, 2017 to 30 June 2018 in Addis Ababa will be included in the study. Interviewer-administered questionnaires will be used to collect information about medical consultations after recognition of symptoms, health-seeking behaviours, treatment received, barriers to early detection and treatment, and survivorship care. In-depth interview will be conducted on purposefully selected women with breast and cervical cancer. The primary outcomes of the study are time intervals (patient and diagnostic waiting times), stage at diagnosis and survival. Multivariable analysis will be employed to determine the contributions of independent variables on the outcomes of interest. HRs with 95% CIs will be calculated for time-to-event outcomes. Qualitative data will be analysed using thematic analysis.
ETHICS AND DISSEMINATION: This protocol is ethically approved by Institutional Review Board of Addis Ababa University. Verbal informed consent will be obtained from study participants. Results will be disseminated in international peer-reviewed journals and presented in relevant conferences.

Keywords

References

  1. J Cancer Surviv. 2011 Sep;5(3):305-14 [PMID: 21274648]
  2. Int J Womens Health. 2017 May 22;9:365-372 [PMID: 28579837]
  3. J Oncol. 2012;2012:121873 [PMID: 22956949]
  4. BMC Cancer. 2013 Jan 02;13:2 [PMID: 23282173]
  5. World J Surg Oncol. 2018 Mar 22;16(1):63 [PMID: 29566711]
  6. Oncologist. 2014 Jul;19(7):727-34 [PMID: 24951611]
  7. Breast Care (Basel). 2015 Dec;10(6):364-70 [PMID: 26989354]
  8. J Cancer Educ. 2017 Dec;32(4):901-907 [PMID: 27075197]
  9. Arch Public Health. 2015 Aug 27;73(1):39 [PMID: 26380083]
  10. J Clin Oncol. 2007 May 20;25(15):2127-32 [PMID: 17513820]
  11. J Exp Clin Cancer Res. 2008 Aug 29;27:32 [PMID: 18759983]
  12. Cancer. 2010 Feb 1;116(3):577-85 [PMID: 20029968]
  13. Cancer. 2012 Sep 15;118(18):4372-84 [PMID: 22252462]
  14. Lancet. 1999 Apr 3;353(9159):1127-31 [PMID: 10209975]
  15. Toxicol In Vitro. 2017 Feb;38:117-123 [PMID: 27737796]
  16. PLoS One. 2016 Mar 10;11(3):e0149908 [PMID: 26963098]
  17. BMC Womens Health. 2015 Sep 16;15:75 [PMID: 26376638]
  18. BMC Cancer. 2013 Feb 08;13:69 [PMID: 23391288]
  19. Cancer Epidemiol. 2018 Apr;53:93-98 [PMID: 29414637]
  20. Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):444-457 [PMID: 28223433]
  21. Obstet Gynecol Int. 2016;2016:1274734 [PMID: 27867397]
  22. ISRN Oncol. 2013 Aug 06;2013:470981 [PMID: 23986873]
  23. BMC Cancer. 2014 Nov 29;14:895 [PMID: 25433805]
  24. PLoS One. 2017 Jul 25;12(7):e0181415 [PMID: 28742851]
  25. Ethiop Med J. 2015 Apr;53(2):65-74 [PMID: 26591294]
  26. Int J Breast Cancer. 2013;2013:814395 [PMID: 24298389]
  27. Oncologist. 2015 Jul;20(7):780-8 [PMID: 26032138]
  28. Gynecol Oncol Res Pract. 2015 Sep 18;2:6 [PMID: 27231566]
  29. J Oncol. 2013;2013:206367 [PMID: 23840209]
  30. Cien Saude Colet. 2015 Oct;20(10):3177-89 [PMID: 26465859]
  31. Health Qual Life Outcomes. 2009 Dec 23;7:102 [PMID: 20030832]
  32. Infect Agent Cancer. 2017 Nov 29;12:61 [PMID: 29213299]
  33. BMC Med Ethics. 2018 Nov 14;19(1):87 [PMID: 30428895]
  34. PLoS One. 2016 Sep 30;11(9):e0163136 [PMID: 27690311]
  35. Int J Gynaecol Obstet. 2009 May;105(2):107-8 [PMID: 19342051]
  36. Int J Equity Health. 2012 Dec 29;11:83 [PMID: 23273140]
  37. Br J Cancer. 2012 Mar 27;106(7):1262-7 [PMID: 22415239]
  38. Int J Cancer. 2014 Aug 1;135(3):702-9 [PMID: 24375396]
  39. Glob Public Health. 2011;6(7):719-31 [PMID: 20865612]
  40. Int J Breast Cancer. 2012;2012:908547 [PMID: 22315692]
  41. J Affect Disord. 2015 Nov 1;186:32-9 [PMID: 26226431]

MeSH Term

Breast Neoplasms
Epidemiologic Research Design
Ethiopia
Female
Follow-Up Studies
Humans
Multicenter Studies as Topic
Prospective Studies
Qualitative Research
Surveys and Questionnaires
Uterine Cervical Neoplasms

Word Cloud

Created with Highcharts 10.0.0willcervicalbreastwomencancerstudytreatmentoutcomesAddisAbabadiagnosedEthiopiacancersnewlystagecarehealth-seekingbehavioursbarriersearlydetectionsurvivalexperiencerecognitionsymptomsdiagnosiscityANDfollow-upusingemployedanalysisprotocolneoplasmINTRODUCTION:CanceremergingpublichealthproblemaccountinghalfmajoritylatediseasepatientsreceiveconsistentglobalstandardsHoweverlittleknownpatient-reportedfinancialburdencountryThereforeaimsdocumentsurvivorship/mortalityMETHODSANALYSIS:prospectivemixedmethodsquantitativequalitative1January201730June2018includedInterviewer-administeredquestionnairesusedcollectinformationmedicalconsultationsreceivedsurvivorshipIn-depthinterviewconductedpurposefullyselectedprimarytimeintervalspatientdiagnosticwaitingtimesMultivariabledeterminecontributionsindependentvariablesinterestHRs95%CIscalculatedtime-to-eventQualitativedataanalysedthematicETHICSDISSEMINATION:ethicallyapprovedInstitutionalReviewBoardUniversityVerbalinformedconsentobtainedparticipantsResultsdisseminatedinternationalpeer-reviewedjournalspresentedrelevantconferencesBreastpatients'Ethiopia:addisababaethiopiareportedoutcomemeasuresuterine

Similar Articles

Cited By (8)